Clinical Trial Update: The Effect of DASH Diet on the Cardiometabolic Risks and Hepatic Function Among Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigated whether the DASH diet affects cardiometabolic risk factors and hepatic function in adults with type 2 diabetes; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Type 2 Diabetic Patients | Phase 4 | Status: COMPLETED